Jones Trading Starts AbCellera Biologics (ABCL) at Buy
Tweet
Share
E-mail
Get Alerts ABCL Hot Sheet
Price: $11.20 -1.58%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Join SI Premium – FREE
Jones Trading analyst Debanjana Chatterjee initiates coverage on AbCellera Biologics (NASDAQ: ABCL) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on AbCellera Biologics click here. For more ratings news on AbCellera Biologics click here.
Shares of AbCellera Biologics closed at $3.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Cadillac Mines Corp (CADY:CN) at Outperform
- BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
- JPMorgan Double Upgrades Hemnet Group AB (HEM:SS) to Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
